Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product

Keyphrases

• Human B Cells 100%
• BCL6 100%
• Oncogene 100%
• Zinc Finger Protein 100%
• Oncogene Products 100%
• Zinc Finger 80%
• Amino Acids 60%
• Proline-rich Region 40%
• Gene Expression 20%
• Myeloid Leukemia 20%
• Disease Genes 20%
• Viral Integration 20%
• C2H2 Zinc Finger Proteins 20%
• Localization Pattern 20%
• Leukemia Disease 20%
• Deletion mutagenesis 20%
• Integration Site 20%
• First Intron 20%
• Immunolocalization Studies 20%
• Acidic Domain 20%
• Transforming Activity 20%
• Interaction Domains 20%
• POZ Domain 20%
• Glutathione S-transferase Pull-down 20%
• Co-immunoprecipitation (co-IP) 20%
• NIH3T3 20%

Biochemistry, Genetics and Molecular Biology

• Proto Oncogene 100%
• BCL6 100%
• B Cell 100%
• Zinc Finger Motif 80%
• Amino Acids 60%
• Proline 40%
• Mutagenesis 20%
• Isoform 20%
• BTB/POZ Domain 20%
• Gene Expression 20%
• Myeloid 20%
• Intron 20%
• Glutathione S-Transferase 20%

Immunology and Microbiology

• B Cell 100%
• BCL6 100%
• Proto Oncogene 100%
• Zinc Finger Motif 80%
• Intron 20%
• Immunolocalization 20%
• Gene Expression 20%
• Myeloid 20%
• BTB-POZ Domain 20%
• Mutagenesis 20%